Kleinzellige Bronchialkarzinome

Wolf, M.

doi:10.1007/978-3-540-28978-4_27

Search citation statements

Order By: Relevance

Paper Sections

Select...

Sclc Je Nach Durchführbarkeit Einer1

Therapie [22]1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(2 citation statements)

References 110 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Um der prognostischen Bedeutung der Tumorausbreitung eher Rechnung zu tragen, kann beim SCLC zusätzlich in Very limited disease (VLD), LD, ED I, ED IIa und ED IIb unterschieden werden. Die 5-JahresÜberlebensraten betragen: VLD und LD 10-15%; ED I 5%; ED II 1% [19].…”

Section: Sclc Je Nach Durchführbarkeit Einerunclassified

See 1 more Smart Citation

Bildgebung als Teil des klinischen Tumorstagings

Brodowicz¹,

Zielinski²

1999

Der Radiologe

View full text Add to dashboard Cite

In order to evaluate the anatomic extension of neoplastic disease according to the TNM system sufficiently, inclusion of imaging techniques is absolutely necessary. In addition, decisions on further clinical processing are based on precise identification of primary tumor extent (T), condition of regional nodes (N) and possible presence of distant metastases (M). Breast cancer, lung cancer, colorectal cancer and prostate cancer represent the most common tumor entities. Within this context the importance of imaging techniques for diagnosis, prognosis, therapy and follow-up of patients with these malignancies is presented in this report.

show abstract

Section: Sclc Je Nach Durchführbarkeit Einerunclassified

“…SCLC [19]. Die zytostatische Polychemotherapie ist die Grundlage für die Behandlungsstrategie beim SCLC.…”

Section: Therapie [22]unclassified